HEARTBURN CANCER UK
HCUK works to raise awareness and to educate the public and the medical profession about heartburn, reflux, Barrett's Oesophagus, oesophageal adenocarcinoma, cardia and related diseases. It provides facilities for the detection and treatment of such diseases, promotes research into causes, prevention, treatment and cure. It supports people suffering from symptoms and also post-operative.
Objects
THE COMPANY HAS BEEN ESTABLISHED FOR THE FOLLOWING OBJECTS (THE 'OBJECTS'):THE RELIEF OF SICKNESS OF PERSONS SUFFERING FROM HEARTBURN, REFLUX, BARRETTS OESOPHAGUS, CARDIA AND CARDIA AND OESOPHAGEAL CANCER AND RELATED DISEASES AND THE PROVISION OF FACILITIES FOR THE DETECTION AND TREATMENT OF THE SAID DISEASES AND BY PAYMENT TOWARDS THE MAINTENANCE AND RUNNING COSTS OF SUCH FACILITIES; AND/ORTHE ADVANCEMENT OF EDUCATION OF THE PUBLIC AND MEDICAL PROFESSION IN ALL ASPECTS OF HEARTBURN, REFLUX, BARRETTS OESOPHAGUS, CARDIA AND CARDIA AND OESOPHAGEAL CANCER AND RELATED DISEASES INCLUDING, BY PROMOTING RESEARCH INTO ITS CAUSES, PREVENTION, TREATMENT AND CURE; AND SUCH OTHER CHARITABLE OBJECTS CONSISTENT WITH THE ABOVE WHICH THE TRUSTEES IN THE ABSOLUTE DISCRETION DETERMINE.
Financial health, per its FY2025 accounts
The accounts state that the charity incurred a net expenditure of £75,539 for the year, resulting in a decline in total funds from £257,940 to £182,401. Despite this downturn in income, the trustees report that the reserves policy target of approximately £45,000 has been maintained throughout the year. The independent examiner confirmed that no matters came to their attention giving cause to believe the accounts were inaccurate or non-compliant.
What the accounts disclose
“It is the policy of the charity that unrestricted funds, which have not been designated for a specific use should be maintained at a level equivalent to six months expenditure, which is calculated to be in the region of £45k.” — page 15
Policies the charity declares
- Bullying and harassment policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Paying staff
- Safeguarding policy and procedures
- Social media policy and procedures
- Trustee expenses policy and procedures
Trustees
- Mimi Erica MCCORDchair
- BERYL ANNE HUNTINGDON
- Dr OLIVER JOHN STOVIN
- Joanna Dawn Stevenson
- Michael John Charles Farrier
- Professor Rebecca Clare Fitzgerald
- Rowena Melynda Somerville-Cotton
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/04/2025 | £217k | £292k |
| 30/04/2024 | £276k | £235k |
| 30/04/2023 | £175k | £116k |
| 30/04/2022 | £168k | £136k |
| 30/04/2021 | £124k | £104k |
Common questions
Is HEARTBURN CANCER UK financially healthy?
Per its FY2025 accounts: The accounts state that the charity incurred a net expenditure of £75,539 for the year, resulting in a decline in total funds from £257,940 to £182,401. Despite this downturn in income, the trustees report that the reserves policy target of approximately £45,000 has been maintained throughout the year. The independent examiner confirmed that no matters came to their attention giving cause to believe the accounts were inaccurate or non-compliant. Its FY2025 accounts were independently examined.
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 07/05/2026 | £20k | Executive Assistant |
| The National Lottery Community Fund | 09/05/2024 | £20k | Building an online community for those with (or at risk of) oesophageal cancer |
| The National Lottery Community Fund | 27/01/2023 | £10k | Support for those with Barrett's and Oesophageal Cancer |
| UK government | 25/11/2019 | £20k | Project DELTA - integrateD diagnostic solution for EarLy deTection of oesophageal cAncer |